{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:49:03Z","timestamp":1764996543702,"version":"3.46.0"},"reference-count":20,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"unspecified","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Federal Ministry of Education and Research, Berlin, Germany","award":["031B0560A","031B0560B","161B0560A","161B0560B"],"award-info":[{"award-number":["031B0560A","031B0560B","161B0560A","161B0560B"]}]},{"name":"TolerogenixX GmbH, Heidelberg, Germany","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2022,10,17]]},"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Donor-derived modified immune cells (MIC) induced long-term specific immunosuppression against the allogeneic donor in preclinical models of transplantation. In a phase I clinical trial (TOL-1 Study), MIC treatment resulted in a cellular phenotype that was directly and indirectly suppressive to the recipient\u2019s immune system allowing for reduction of conventional immunosuppressive therapy. Here, we describe a protocol for a randomised controlled, multicentre phase-IIb clinical trial of individualised immunosuppression with intravenously administered donor MIC compared with standard-of-care (SoC) in living donor kidney transplantation (TOL-2 Study).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>Sixty-three living donor kidney transplant recipients from six German transplant centres are randomised 2:1 to treatment with MIC (MIC group, N=42) or no treatment with MIC (control arm, N=21). MIC are manufactured from donor peripheral blood mononuclear cells under Good Manufacturing Practice conditions. The primary objective of this trial is to determine the efficacy of MIC treatment together with reduced conventional immunosuppressive therapy in terms of achieving an operational tolerance-like phenotype compared with SoC 12 months after MIC administration. Key secondary endpoints are the number of patient-relevant infections as well as a composite of biopsy-proven acute rejection, graft loss, graft dysfunction or death. Immunosuppressive therapy of MIC-treated patients is reduced during follow-up under an extended immunological monitoring including human leucocyte antigen-antibody testing, and determination of lymphocyte subsets, for example, regulatory B lymphocytes (Breg) and antidonor T cell response. A Data Safety Monitoring Board has been established to allow an independent assessment of safety and efficacy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethical approval has been provided by the Ethics Committee of the Medical Faculty of the University of Heidelberg, Heidelberg, Germany (AFmu-580\/2021, 17 March 2022) and from the Federal Institute for Vaccines and Biomedicines, Paul-Ehrlich-Institute, Langen, Germany (Vorlage-Nr. 4586\/02, 21 March 2022). Written informed consent will be obtained from all patients and respective donors prior to enrolment in the study. The results from the TOL-2 Study will be published in peer-reviewed medical journals and will be presented at symposia and scientific meetings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05365672\">NCT05365672<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2022-066128","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T10:05:30Z","timestamp":1668161130000},"page":"e066128","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trial"],"prefix":"10.1136","volume":"12","clinical-trial-number":[{"clinical-trial-number":"nct05365672","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2218-7817","authenticated-orcid":false,"given":"Christian","family":"Morath","sequence":"first","affiliation":[{"name":"TolerogenixX GmbH, Heidelberg, Germany"},{"name":"Department of Nephrology, Heidelberg University Hospital, Heidelberg, Germany"},{"name":"German Center for Infection Research, DZIF, TTU-IICH, Partner site Heidelberg, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Schmitt","sequence":"additional","affiliation":[{"name":"TolerogenixX GmbH, Heidelberg, Germany"},{"name":"Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Schmitt","sequence":"additional","affiliation":[{"name":"TolerogenixX GmbH, Heidelberg, Germany"},{"name":"Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[{"name":"TolerogenixX GmbH, Heidelberg, Germany"},{"name":"Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Kleist","sequence":"additional","affiliation":[{"name":"TolerogenixX GmbH, Heidelberg, Germany"},{"name":"Institute of Immunology, Heidelberg University Hospital, Heidelberg, Germany"},{"name":"Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Opelz","sequence":"additional","affiliation":[{"name":"TolerogenixX GmbH, Heidelberg, Germany"},{"name":"Institute of Immunology, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caner","family":"S\u00fcsal","sequence":"additional","affiliation":[{"name":"Institute of Immunology, Heidelberg University Hospital, Heidelberg, Germany"},{"name":"Transplant Immunology Research Center of Excellence, Ko\u00e7 University, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. Hien","family":"Tran","sequence":"additional","affiliation":[{"name":"Institute of Immunology, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Scherer","sequence":"additional","affiliation":[{"name":"Institute of Immunology, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vedat","family":"Schwenger","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Transplant Center, Klinikum der Landeshauptstadt Stuttgart, Stuttgart, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1242-4914","authenticated-orcid":false,"given":"Stephan","family":"Kemmner","sequence":"additional","affiliation":[{"name":"Transplant Center, University Hospital Munich, Ludwig-Maximilians University (LMU), Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Fischereder","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine IV, University Hospital Munich, Ludwig-Maximilians University Munich (LMU), Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Stangl","sequence":"additional","affiliation":[{"name":"Department of General, Visceral, and Transplant Surgery, University Hospital Munich, Ludwig-Maximilians University Munich (LMU), Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingeborg A.","family":"Hauser","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Sommerer","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Heidelberg University Hospital, Heidelberg, Germany"},{"name":"German Center for Infection Research, DZIF, TTU-IICH, Partner site Heidelberg, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Nusshag","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"K\u00e4lble","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3668-5916","authenticated-orcid":false,"given":"Claudius","family":"Speer","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Benning","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Bischofs","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Sauer","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria-Luisa","family":"Schubert","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Kunz","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"H\u00fcckelhoven-Krauss","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Neuber","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6163-1525","authenticated-orcid":false,"given":"Arianeb","family":"Mehrabi","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantin","family":"Schwab","sequence":"additional","affiliation":[{"name":"Institut of Pathology, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00fcdiger","family":"Waldherr","sequence":"additional","affiliation":[{"name":"Institut of Pathology, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Sander","sequence":"additional","affiliation":[{"name":"Institut of Medical Biometry, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"B\u00fcsch","sequence":"additional","affiliation":[{"name":"Institut of Medical Biometry, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Czock","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg A","family":"B\u00f6hmig","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen","family":"Reiser","sequence":"additional","affiliation":[{"name":"Department of Medicine, Rush University, Chicago, Illinois, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Roers","sequence":"additional","affiliation":[{"name":"Institute of Immunology, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"M\u00fcller-Tidow","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Terness","sequence":"additional","affiliation":[{"name":"TolerogenixX GmbH, Heidelberg, Germany"},{"name":"Institute of Immunology, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Zeier","sequence":"additional","affiliation":[{"name":"TolerogenixX GmbH, Heidelberg, Germany"},{"name":"Department of Nephrology, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volker","family":"Daniel","sequence":"additional","affiliation":[{"name":"Institute of Immunology, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Schaier","sequence":"additional","affiliation":[{"name":"TolerogenixX GmbH, Heidelberg, Germany"},{"name":"Department of Nephrology, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,11,11]]},"reference":[{"key":"2025120520340477000_12.11.e066128.1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03840.x"},{"key":"2025120520340477000_12.11.e066128.2","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1111\/ajt.12313","article-title":"Association between steroid dosage and death with a functioning graft after kidney transplantation","volume":"13","author":"Opelz","year":"2013","journal-title":"Am J Transplant"},{"key":"2025120520340477000_12.11.e066128.3","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1172\/JCI133595","article-title":"Phase I trial of donor-derived modified immune cell infusion in kidney transplantation","volume":"130","author":"Morath","year":"2020","journal-title":"J Clin Invest"},{"key":"2025120520340477000_12.11.e066128.4","first-page":"ASN.2022020210","article-title":"Induction of long-lasting regulatory B lymphocytes by modified immune cells in kidney transplant recipients","author":"Morath","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"2025120520340477000_12.11.e066128.5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00467-017-3599-2","article-title":"Cell therapeutic approaches to immunosuppression after clinical kidney transplantation","volume":"33","author":"Morath","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"2025120520340477000_12.11.e066128.6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0807185105"},{"key":"2025120520340477000_12.11.e066128.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2011.12.032"},{"key":"2025120520340477000_12.11.e066128.8","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.humimm.2015.06.008","article-title":"Immunosuppressive properties of mitomycin C-incubated human myeloid blood cells (MIC) in vitro","volume":"76","author":"Dittmar","year":"2015","journal-title":"Hum Immunol"},{"key":"2025120520340477000_12.11.e066128.9","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1042\/CS20140258","article-title":"Generation of suppressive blood cells for control of allograft rejection","volume":"128","author":"Kleist","year":"2015","journal-title":"Clin Sci"},{"key":"2025120520340477000_12.11.e066128.10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00423-017-1616-3","article-title":"The combination of mitomycin-induced blood cells with a temporary treatment of ciclosporin a prolongs allograft survival in vascularized composite allotransplantation","volume":"403","author":"Radu","year":"2018","journal-title":"Langenbecks Arch Surg"},{"key":"2025120520340477000_12.11.e066128.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067411"},{"key":"2025120520340477000_12.11.e066128.12","doi-asserted-by":"publisher","DOI":"10.1172\/JCI39933"},{"key":"2025120520340477000_12.11.e066128.13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI39922"},{"key":"2025120520340477000_12.11.e066128.14","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2119\/molmed.2011.00281","article-title":"Preserving the B-cell compartment favors operational tolerance in human renal transplantation","volume":"18","author":"Silva","year":"2012","journal-title":"Mol Med"},{"key":"2025120520340477000_12.11.e066128.15","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/MOT.0000000000000204","article-title":"Role of B cells in tolerance induction","volume":"20","author":"Kim","year":"2015","journal-title":"Curr Opin Organ Transplant"},{"key":"2025120520340477000_12.11.e066128.16","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014040404"},{"key":"2025120520340477000_12.11.e066128.17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trim.2017.02.004","article-title":"Regulatory B cells: phenotype, function and role in transplantation","volume":"41","author":"Wortel","year":"2017","journal-title":"Transpl Immunol"},{"key":"2025120520340477000_12.11.e066128.18","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0152-y"},{"key":"2025120520340477000_12.11.e066128.19","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/tri.13706","article-title":"Regulatory B cells in transplantation: roadmaps to clinic","volume":"33","author":"Beckett","year":"2020","journal-title":"Transpl Int"},{"key":"2025120520340477000_12.11.e066128.20","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1111\/ajt.14329","article-title":"Real time central assessment of kidney transplant indication biopsies by microarrays: the INTERCOMEX study","volume":"17","author":"Halloran","year":"2017","journal-title":"Am J Transplant"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2022-066128","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:34:15Z","timestamp":1764995655000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2022-066128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":20,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11,11]]},"published-print":{"date-parts":[[2022,11]]}},"alternative-id":["10.1136\/bmjopen-2022-066128"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2022-066128","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2022,11]]}}}